Pfizer Inc. (PFE)
NYSE: PFE
· Real-Time Price · USD
24.88
0.34 (1.39%)
At close: Sep 05, 2025, 3:59 PM
24.85
-0.12%
After-hours: Sep 05, 2025, 07:56 PM EDT
Pfizer Revenue Breakdown
| Period Ending | Jun 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biopharma Segment Revenue | 14.3B | 17.41B | 17.39B | 12.99B | 14.6B | 13.87B | 12.93B | 12.42B | 17.97B | 23.92B | 22.32B | 27.43B | 25.32B | 10.21B | 9.79B | 10.01B | 10.53B | 10.11B | 9.6B | 9.19B |
| Biopharma Segment Revenue Growth | -17.85% | +0.12% | +33.88% | -11.04% | +5.31% | +7.25% | +4.12% | -30.90% | -24.87% | +7.18% | -18.62% | +8.30% | +147.90% | +4.29% | -2.12% | -4.98% | +4.18% | +5.35% | +4.46% | n/a |
Revenue by Geography
| Period Ending | Jun 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Dec 31, 2021 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Dec 31, 2015 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 | Dec 31, 2014 | Sep 28, 2014 | Jun 29, 2014 | Mar 30, 2014 | Dec 31, 2013 | Sep 29, 2013 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jul 1, 2012 | Apr 1, 2012 | Dec 31, 2011 | Oct 2, 2011 | Jul 3, 2011 | Apr 3, 2011 | Oct 3, 2010 | Jul 4, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Developed Rest Of World Revenue | 3.39B | 6.28B | 3.41B | 3.16B | 3.2B | 2.91B | 1.07B | 1.3B | 2.47B | 5.11B | 2.35B | 5.03B | 3.29B | 3.89B | 4.5B | 3B | 1.12B | -606M | 1.63B | 1.55B | 1.46B | 1.71B | 1.58B | 1.64B | 1.53B | 1.76B | 1.64B | 1.69B | 1.46B | 1.81B | 1.63B | 1.61B | 1.55B | 1.78B | 1.71B | 1.72B | 1.52B | 1.73B | 1.51B | 1.56B | 1.49B | 1.91B | 1.82B | 1.86B | 1.73B | 2.07B | 1.99B | 2.11B | 2.17B | 2.7B | 2.53B | 2.69B | 2.63B | 3.03B | 2.84B | 2.67B | 2.55B | 2.38B | 2.71B |
| Developed Rest Of World Revenue Growth | -46.00% | +84.14% | +7.84% | -1.06% | +9.90% | +171.20% | -17.78% | -47.23% | -51.58% | +117.23% | -53.30% | +53.20% | -15.48% | -13.56% | +50.08% | +166.87% | -285.31% | -137.09% | +5.28% | +6.59% | -14.65% | +7.63% | -3.29% | +6.78% | -12.59% | +7.07% | -3.19% | +15.95% | -19.50% | +11.21% | +1.30% | +3.67% | -12.70% | +4.03% | -0.41% | +13.03% | -12.34% | +14.61% | -2.89% | +4.35% | -21.79% | +5.12% | -2.42% | +7.70% | -16.68% | +4.12% | -5.50% | -2.95% | -19.47% | +6.64% | -6.09% | +2.20% | -13.09% | +6.76% | +6.25% | +4.99% | +7.11% | -12.26% | n/a |
| Emerging Markets Revenue | 2.37B | 2.26B | 2.23B | 2.23B | 2.17B | 2.31B | 2.37B | 2.83B | 4.48B | 3.42B | 3.3B | 6.01B | 7.37B | 7.77B | 6.3B | 3.81B | 2.82B | -82M | 2.69B | 2.76B | 3B | 3.24B | 3.11B | 3.06B | 3.32B | 3.29B | 3.07B | 3.21B | 3.08B | 3.18B | 2.84B | 2.81B | 2.57B | 2.69B | 2.59B | 2.65B | 2.49B | 2.9B | 2.69B | 2.92B | 2.63B | 3.08B | 2.87B | 3B | 2.56B | 2.75B | 2.68B | 2.86B | 2.93B | 2.76B | 2.84B | 3.15B | 3.22B | 3.31B | 3.4B | 3.35B | 3.05B | 2.84B | 3.1B |
| Emerging Markets Revenue Growth | +4.74% | +1.48% | -0.04% | +2.77% | -6.39% | -2.44% | -16.09% | -36.88% | +30.84% | +3.76% | -45.05% | -18.47% | -5.20% | +23.43% | +65.25% | +34.92% | -3543.90% | -103.04% | -2.36% | -8.06% | -7.35% | +4.15% | +1.57% | -7.83% | +0.88% | +7.40% | -4.60% | +4.42% | -3.15% | +11.94% | +0.85% | +9.66% | -4.57% | +4.02% | -2.60% | +6.67% | -14.02% | +7.46% | -7.77% | +11.23% | -14.74% | +7.47% | -4.40% | +17.34% | -7.16% | +2.69% | -6.36% | -2.35% | +6.27% | -3.02% | -9.57% | -2.45% | -2.60% | -2.65% | +1.61% | +9.78% | +7.25% | -8.17% | n/a |
| United States Revenue | 8.89B | 9.22B | 12.06B | 7.89B | 9.51B | 4.59B | 7.8B | 6.18B | 8.51B | 8.48B | 13.85B | 11.22B | 8.92B | 7.48B | 7.08B | 7.59B | 7.6B | 4.94B | 5.72B | 5.4B | 5.65B | 5.49B | 5.85B | 6.33B | 6.17B | 6.47B | 6.36B | 6.22B | 6.28B | 6.51B | 6.53B | 6.34B | 6.64B | 6.88B | 6.53B | 6.33B | 6.63B | 6.71B | 5.57B | 4.99B | 4.43B | 5.05B | 4.84B | 4.91B | 4.28B | 4.63B | 5.19B | 5.09B | 5.37B | 5.78B | 5.63B | 5.72B | 5.95B | 6.33B | 6.88B | 6.7B | n/a | 7.11B | 7.38B |
| United States Revenue Growth | -3.55% | -23.57% | +52.86% | -17.05% | +107.19% | -41.16% | +26.18% | -27.30% | +0.29% | -38.76% | +23.43% | +25.84% | +19.27% | +5.62% | -6.77% | -0.05% | +53.69% | -13.52% | +5.81% | -4.41% | +2.90% | -6.12% | -7.66% | +2.59% | -4.53% | +1.68% | +2.18% | -0.80% | -3.61% | -0.37% | +2.98% | -4.40% | -3.52% | +5.34% | +3.08% | -4.38% | -1.30% | +20.61% | +11.43% | +12.66% | -12.22% | +4.30% | -1.30% | +14.76% | -7.67% | -10.72% | +1.89% | -5.18% | -7.18% | +2.77% | -1.66% | -3.90% | -5.94% | -7.98% | +2.67% | n/a | n/a | -3.64% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 29, 2025 | Mar 29, 2025 | Dec 31, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Dec 31, 2021 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Dec 31, 2015 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.4B | 3.02B | 4.23B | 3.24B | 3.69B | 3.46B | 4.47B | 3.21B | 3.43B | 3.36B | 4.43B | 3.25B | 2.91B | 2.52B | 3.96B | 2.75B | 2.83B | 2.71B | 3.67B | 2.62B | 2.6B | 2.53B | 4.21B | 3.24B | 3.49B | 3.33B | 3.99B | 3.48B | 3.53B | 3.4B | 4.53B | 3.48B | 3.42B | 3.3B | 4.4B | 3.54B | 3.47B | 3.38B | 5.05B | 3.27B | 3.39B | 3.1B |
| Selling, General, and Administrative Revenue Growth | +12.50% | -28.44% | +30.51% | -12.20% | +6.62% | -22.62% | +39.17% | -6.41% | +2.23% | -24.17% | +36.05% | +11.67% | +15.68% | -36.47% | +44.23% | -2.76% | +4.20% | -26.08% | +39.97% | +1.00% | +2.77% | -40.06% | +30.18% | -7.36% | +4.96% | -16.48% | +14.64% | -1.39% | +3.86% | -25.06% | +30.25% | +1.84% | +3.52% | -24.99% | +24.38% | +1.87% | +2.54% | -32.94% | +54.37% | -3.43% | +9.09% | n/a |
| Research and Development Revenue | 2.44B | 2.18B | 3.02B | 2.56B | 2.68B | 2.48B | 2.77B | 2.68B | 2.63B | 2.49B | 3.62B | 2.7B | 2.81B | 2.3B | 5.92B | 2.68B | 2.24B | 1.99B | 3.35B | 2.3B | 2.08B | 1.68B | 2.81B | 2.28B | 1.83B | 1.7B | 2.44B | 2B | 1.79B | 1.74B | 2.3B | 1.85B | 1.78B | 1.7B | 2.5B | 1.87B | 1.75B | 1.73B | 2.35B | 1.72B | 1.73B | 1.89B |
| Research and Development Revenue Growth | +12.12% | -27.78% | +17.62% | -4.15% | +7.90% | -10.57% | +3.39% | +2.02% | +5.41% | -31.01% | +34.09% | -4.23% | +22.34% | -61.10% | +120.63% | +19.74% | +12.29% | -40.51% | +45.80% | +10.80% | +23.73% | -40.41% | +23.42% | +24.52% | +7.96% | -30.49% | +22.06% | +11.68% | +3.05% | -24.61% | +24.54% | +4.17% | +4.41% | -32.01% | +33.65% | +7.09% | +0.98% | -26.28% | +36.35% | -0.69% | -8.01% | n/a |